No Chart Data Available
No Record Found
No Record Found
Sector
HealthcareOpen
₹694.05Prev. Close
₹697.15Turnover(Lac.)
₹10,877.93Day's High
₹712.2Day's Low
₹684.2552 Week's High
₹891.352 Week's Low
₹519.1Book Value
₹49.07Face Value
₹10Mkt Cap (₹ Cr.)
61,792.86P/E
199.65EPS
3.55Divi. Yield
0.255 Aug 2026
12:00 AM
AGM
Announcement Date: 05 Aug, 2026
30 Jul 2026
12:00 AM
Board Meeting
Agenda : Audited Result
26 Mar 2026
12:00 AM
Dividend
Dividend Amount: 3
Record Date: 03 Apr, 2026
4 Feb 2026
12:00 AM
EGM
For the quarter ended June 30, 2025, Aster reported a consolidated revenue of ₹1,078 crore. This is up 8% from ₹1,002 crore in the same period last year.
EBITDA increased 20.3% to ₹191.7 crore in the March 2025 quarter from ₹159.4 crore a year ago.
Over the next 5 years (FY25-FY29), the India business is expected to grow at a CAGR of approximately 18% - 20% YoY.
This project aims to improve medical outcomes and access to quality care in Hyderabad and nearby areas.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 518.13 | 499.52 | 499.52 | 499.52 |
Preference Capital | 374.38 | 374.38 | 374.38 | 374.38 |
Reserves | 3,473.71 | 2,465.59 | 2,420.34 | 2,256.66 |
Net Worth | 4,366.22 | 3,339.49 | 3,294.24 | 3,130.56 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,116.47 | 746.54 | 760.42 | 530.06 |
yoy growth (%) | 49.55 | -1.82 | 43.45 | 39.67 |
Raw materials | -273.54 | -185.88 | -186.26 | -147.83 |
As % of sales | 24.5 | 24.89 | 24.49 | 27.88 |
Employee costs | -172.09 | -143.78 | -130.42 | -106.07 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 89.96 | -68.04 | 64.61 | -87.19 |
Depreciation | -98.72 | -95 | -89.32 | -59.07 |
Tax paid | 0.22 | -0.74 | -4 | 0 |
Working capital | 21.48 | -9.48 | -261.2 | 105.73 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 49.55 | -1.82 | 43.45 | 39.67 |
Op profit growth | 259.78 | -42.39 | 646.27 | -120.6 |
EBIT growth | -524.79 | -132.24 | -394.27 | -60.5 |
Net profit growth | -231.11 | -213.47 | -169.51 | -286.68 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 4,643.22 | 4,138.46 | 3,698.9 | 2,994.05 | 10,253.28 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,643.22 | 4,138.46 | 3,698.9 | 2,994.05 | 10,253.28 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 125.6 | 5,219.43 | 31.73 | 352.8 | 51.2 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 8,133.5 | 73.87 | 1,16,695.63 | 385.2 | 0.25 | 2,656.1 | 692.92 |
Max Healthcare Institute Ltd MAXHEALTH | 940.95 | 125.81 | 91,963.22 | 167.6 | 0.21 | 782.92 | 91.83 |
Manipal Health Enterprises Ltd MANIPALHOS | 696 | 219.48 | 91,517.37 | 115.53 | 0 | 1,048.3 | 116.5 |
Aster DM Quality Care Ltd ASTERDM | 708.9 | 199.65 | 61,779.78 | -14.3 | 0.25 | 725.73 | 49.23 |
Fortis Healthcare Ltd FORTIS | 785 | 297.69 | 59,332.16 | 47.78 | 0.13 | 489.45 | 122.24 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
Mandayapurath Azad Moopen
ED / Deputy MD / Promoter
Alisha Moopen
Non-Exec & Non-Independent Dir
Zeba Azad Moopen
Non-Exec & Non-Independent Dir
Thadathil Wilson
Non-Exec & Non-Independent Dir
Shamsudheen Bin Mohideen Mammu Haji
Independent Non Exe. Director
C J George
Independent Non Exe. Director
Mr. Emmanuel David Gootam
Independent Non Exe. Director
M Madhavan Nambiar
Independent Non Exe. Director
DEEPTI PURANA HOUSDURGAMVIJAYA
Independent Non Exe. Director
Sunil Theckath
Independent Non Exe. Director
James Mathew
Company Sec. & Compli. Officer
Hemish Purushottam
7-1-450/20 Plot No 04 Ameerpet,
Mythri Vihar Sanjeev Reddynagr,
Telangana - 500038
Tel: 91-0484-6699228
Website: http://www.asterdmhealthcare.com
Email: cs@asterdmhealthcare.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Aster DM Healthcare Limited was erstwhile established as Aster DM Healthcare Private Limited, a private limited company on 18 January, 2008. On November 29, 2013. The Company was converted into a publ...
Read More
Reports by Aster DM Quality Care Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
